arrow
S

Soffia Guðbjörnsdóttir

university of gothenburg
H指数:67
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case–control study

2型糖尿病常规临床实践中使用SGLT2抑制剂引起的酮症酸中毒:斯堪的纳维亚队列和巢式病例对照研究

2026-09-010
PRE
Pharmacological treatment patterns and outcomes according to the coexistence of heart failure and Type 2 diabetes: data from the Swedish Heart Failure Registry and National Diabetes Registry

根据心力衰竭和2型糖尿病共存情况的心力衰竭药物治疗方法及结局:来自瑞典心力衰竭登记册和全国糖尿病登记册的数据

2026-01-011
PRE
Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide registry-based cohort study

De Novo可植入式心律转复除颤器在伴有和不伴有2型糖尿病患者中的适用指征、预后及并发症:一项基于全国注册登记的队列研究

2025-12-310
OAAI
Impact of type 2 diabetes on the relationship between chronic kidney disease and cardiovascular outcomes in heart failure across ejection fraction: observational study from the Swedish heart failure and the Swedish National diabetes registries

2型糖尿病对射血分数不同水平的心力衰竭患者中,慢性肾脏疾病与心血管结局关系的影响:来自瑞典心力衰竭登记册和瑞典国家糖尿病登记册的观察性研究

2025-12-010
OAAI
Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)

尿酸与1型糖尿病年轻患者未来并发症的关系:来自瑞典糖尿病发病率研究(DISS)和瑞典国家糖尿病登记系统(NDR)的结果

2025-10-140
OA
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries
2024-04-170
OAAI
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data

通过使用人工智能在公开数据上协助实施1型糖尿病筛查

2024-02-141
OAAI